We provide evidence from clinical trials based on GCP-compliant, manufacturer-independent digital, decentralised, or site-based clinical investigations (trials for medical devices). Our services cover all phases of clinical trials—study planning, conduct, and analysis—and are seamlessly integrated with our Digital Trials Manager, a technology specialized in digital studies.
Within the framework of hybrid or fully digital studies, MEDIACC offers the use of a dedicated study platform. This platform enables electronic collection, management, and processing of clinical trial data. For those wishing to leverage the advantages of digitally managed studies, MEDIACC recommends study management via a study platform—even when site-based study centres are involved. Of course, it is still possible to conduct a traditional, predominantly paper-based study; however, based on our extensive experience and scientific evaluations, we believe the benefits of a study platform are clear—particularly in terms of significantly reduced personnel requirements for data collection, as well as improved data quality and plausibility.
MEDIACC is your partner for elegant, efficient clinical trials for your medical device—working with you and for your patients. We rise to your challenges and support your product with individual or comprehensive consulting and services for both traditional and fully digital clinical trials (DDCT-MED®), all from a single source. With our digital trial centre (DTC-MED®), you have access to a highly specialised team ranging from study assistants and investigators to principal investigators. Our experts are deeply familiar with the regulatory landscape of European and national evidence generation, as well as the practical challenges of clinical trials, and understand your business objectives.
For further, detailed information on the technical and procedural aspects of DDCT-MED® and DTC-MED®, please contact us during the conceptualization phase of your hybrid or fully digital clinical study.
